Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real‐world clinical setting. (30th July 2019) - Fougerousse, A.‐C.; Maccari, F.; Beauchet, A.; Parier, J.; Boulard, C.; Becherel, P.‐A.; Quiles‐Tsimaratos, N.; Le Guyadec, T.; Thomas‐Beaulieu, D.; Halioua, B.; Begon, E.; Bastien, M.; et al.